Friedrich Hahn

10PUBLICATIONS
14CO-AUTHORS
Major global burdens of diseaseBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyParticle physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 28, 2026
Identification of a New Phosphorylated Host Interactor of the Epstein-Barr Virus (EBV) Kinase BGLF4 Suggests Key Points for EBV-Specific Antiviral Drug Targeting.

Melanie Kögler, Christina Wangen, Alena Hammerschmitt

|Oct 29, 2025
New Assay Systems to Characterize the Broad-Spectrum Antiherpesviral and Non-Herpesviral Activity of Cyclin-Dependent Kinase (CDK) 8 Inhibitors.

Debora Obergfäll, Friedrich Hahn, Jintawee Kicuntod

|Sep 28, 2024
Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral Strategies.

Debora Obergfäll, Markus Wild, Mona Sommerer

|Aug 29, 2024
Establishment of a Luciferase-Based Reporter System to Study Aspects of Human Cytomegalovirus Infection, Replication Characteristics, and Antiviral Drug Efficacy.

Julia Tillmanns, Jintawee Kicuntod, Antonia Ehring

|Feb 24, 2024
An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity.

DongHoon Yu, Sabrina Wagner, Martin Schütz

|May 16, 2023
Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral Target.

Julia Tillmanns, Sigrun Häge, Eva Maria Borst

Pageof 2

Frequent Collaborators

3 joint publications

Benedikt Kaufer

2 joint publications

Svetlana B Tsogoeva

2 joint publications

Jan Eickhoff

2 joint publications

Bert Klebl